“We announced the distribution partnership in June and following product training for the French team at our headquarter in Uppsala in early July, it is very encouraging to see that market activities have picked up immediately and that our partner has placed a first order to support these. The French market is starting to adopt to rapid AST solutions for positive blood cultures and, as the first tenders are currently issued, it is a very good time to participate in evaluations and customer trials,” commented Thomas Fritz, CCO at Q-linea.

About ASTar Instrument and ASTar BC G- Kit
ASTar Instrument and ASTar BC G- Kit already deliver the broadest answer regarding the combination of the number of antibiotics and the number of double dilution steps of each antibiotic, in a single analysis for gram-negative bacteria. The test enables the analysis of gram-negative bacteria, including difficult-to-grow so-called fastidious bacteria, which satisfies the need for rapid and comprehensive results to support optimal treatment decisions.

ASTar Instrument and ASTar BC G- Kit are CE-marked but not FDA 510(k)-cleared and not available for sale in the United States.